CompletedPhase 3

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

France34 participantsStarted 2005-02

Plain-language summary

Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a double-blind randomized study for evaluation of efficacy and safety of etanercept versus intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * must be able to understand the information about the study * diagnosis of rheumatoid arthritis for 6 month at least * suffering for 2 weeks at least * with evaluation of pain over 4/10 * with stable DMARDs treatment for three month at least Exclusion Criteria: * infection or surgery on the target joint * treated with infliximab,adalimumab or anakinra

What they're measuring

Pain

Timeframe: every month during six month

Trial details

NCT IDNCT00522184

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Rheumatoid Arthritis trials